Albert J Allen Selected Research

Therapeutics

8/2009	A randomized, double-blind, placebo-controlled study of atomoxetine in Japanese children and adolescents with attention-deficit/hyperactivity disorder.
1/2008	Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder.
9/2007	A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder.
2/2004	Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Albert J Allen Research Topics

Disease

43	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2017 - 01/2002
2	Tics (Tic) 01/2008 - 05/2005
1	Body Weight (Weight, Body) 05/2014
1	Dyslexia (Alexia) 12/2009
1	Vomiting 08/2009
1	Chemical and Drug Induced Liver Injury 01/2008
1	Tourette Syndrome (Tourette's Syndrome) 01/2008
1	Jaundice (Icterus) 01/2008
1	Wounds and Injuries (Trauma) 01/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2007
1	Sudden Death 09/2007
1	Major Depressive Disorder (Major Depressive Disorders) 08/2007
1	Nausea 08/2007
1	Epilepsy (Aura) 07/2007
1	Seizures (Absence Seizure) 07/2007
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2006
1	Oppositional Defiant Disorder 08/2004
1	Sleepiness 07/2004
1	Syndrome (Syndromes) 07/2004
1	Fatigue 07/2004

Drug/Important Bio-Agent (IBA)

40	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2017 - 01/2002
8	Methylphenidate (Ritalin)FDA LinkGeneric 05/2014 - 12/2006
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2014 - 06/2008
3	alpha- ((5- fluoro- 2- methoxyphenyl)methyl)- alpha- (tetrahydro- 2H- pyran- 4- yl)- 2- morpholinemethanolIBA 05/2014 - 08/2012
2	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 08/2009 - 02/2004
2	Amphetamine (Amfetamine)FDA LinkGeneric 05/2008 - 06/2007
1	AmphetaminesIBA 03/2013
1	3,4-dihydroxyphenylglycolIBA 08/2012
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 08/2009
1	Biomarkers (Surrogate Marker)IBA 09/2007

Therapy/Procedure

4	Therapeutics 08/2009 - 02/2004